Bismuth subcitrate / metronidazole / tetracycline Oral Capsule [Pylera]
RxNorm 705864
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 705864 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: bismuth subcitrate / metronidazole / tetracycline Oral Capsule [Pylera].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDFPrescribable
Semantic Branded Drug Form (SBDF):
Bismuth subcitrate / metronidazole / tetracycline Oral Capsule [Pylera]
(Atom ID: 12313924)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
Bismuth subcitrate / metroNIDAZOLE / tetracycline Oral Capsule [Pylera]
(Atom ID: 12379813)
Patient Education
Bismuth, Metronidazole, and Tetracycline
Bismuth, metronidazole, and tetracycline is used along with other ulcer medications to treat duodenal ulcers. It is in a class of medications called antibacterial agents. It works by preventing the growth and spread of Helicobacter pylori bacteria, which often occurs with ulcers. Treating this infection keeps ulcers from coming back.
[Learn More]
* Please review the disclaimer below.